Profil
Matthew Outten is currently Chief Commercial Officer at QED Therapeutics, Inc. and Chief Commercial Officer at BridgeBio Pharma, Inc. Formerly, Mr. Outten was Vice President-Marketing & Marketing Access at Pharmacyclics LLC from 2013 to 2018.
Education includes an undergraduate degree from Hamilton College (New York) and an MBA from the University of Delaware.
Aktiva positioner av Matthew Outten
| Företag | Position | Start |
|---|---|---|
| BRIDGEBIO PHARMA, INC. | Företagsledare/Principal | 2019-02-01 |
QED Therapeutics, Inc.
QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Företagsledare/Principal | - |
Tidigare kända positioner av Matthew Outten
| Företag | Position | Slut |
|---|---|---|
| PHARMACYCLICS, INC. | Företagsledare/Principal | - |
Matthew Outtens utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Hamilton College (New York)
Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
QED Therapeutics, Inc.
QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
















